Scott Giacobello, CPA


Scott Giacobello, CPA

Mr. Giacobello currently serves as Aadi’s Chief Financial Officer, joining the Company in November 2021. He had previously served as the CFO for GW Pharmaceuticals, playing a key role in the buildout of U.S. operations and commercial readiness for the launch of their lead product, EPIDIOLEX®, which had sales of over $296 million in its first full year of commercialization. Mr. Giacobello led the company’s financing strategy, raising more than $620 million to support this development, approval, and product launch leading up to their eventual acquisition by Jazz Pharmaceuticals in 2021. Mr. Giacobello had previously served as CFO of Chase Pharmaceuticals Corporation prior to its acquisition by Allergan plc, where he held senior level finance roles including Vice President of Finance, Global Research and Development.

/ Leadership

Share the Post

About the Author